Figure 2 | Scientific Reports

Figure 2

From: Cetuximab inhibits colorectal cancer development through inactivating the Wnt/β-catenin pathway and modulating PLCB3 expression

Figure 2

KM survival analysis of PLCB3 gene in CRC patients with expression analysis in different datasets. (A) Survival curves of PPS probabilities for PLCB3. The horizontal axis represents survival time in years, while the vertical axis represents the probability of PPS. Orange lines correspond to high gene expression, while blue lines indicate low gene expression. HR and P values for high and low expression for each gene are shown in the upper right corner of each plot. (B) Differential expression of PLCB3 between case and control groups in the GSE140973 gene expression dataset. (C) The Wilcoxon rank sum test compared PLCB3 expression levels between 455 COAD samples and 41 adjacent non-tumor samples from the TCGA database. *P < 0.05, **P < 0.01, ***P < 0.001.

Back to article page